Economic and Disease Burden of Dengue in Mexico

PLoS Neglected Tropical Diseases

Volumn 9, Issue 3, 2015, Pages

  Undurraga, Eduardo A ^a   Betancourt Cravioto, Miguel ^b   Ramos Castañeda, José ^c,d   Martínez Vega, Ruth ^c,e   Méndez Galván, Jorge ^f   Gubler, Duane J ^g   Guzmán, María G ^h   Halstead, Scott B ⁱ   Harris, Eva ^j   Kuri Morales, Pablo ^k   Tapia Conyer, Roberto ^b   Shepard, Donald S ^a  

^a BRANDEIS UNIVERSITY   (United States)

^b Carlos Slim Health Institute City   (Mexico)

^c INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^d University of Texas Medical Branch School of Medicine   (United States)

^e Organización Latinoamericana Para El Fomento de la Investigación en Salud   (Colombia)

^f HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^g DUKE NUS MEDICAL SCHOOL   (Singapore)

^h INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

ⁱ Pediatric Dengue Vaccine Initiative   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k Ministry of Health City   (Mexico)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; AWARENESS; COMORBIDITY; DENGUE; DISEASE SEVERITY; DISEASE SURVEILLANCE; ECONOMIC ASPECT; FOLLOW UP; HEALTH CARE POLICY; HUMAN; INCIDENCE; MONTE CARLO METHOD; PROSPECTIVE STUDY; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; TOURISM; VECTOR CONTROL; ADULT; BUDGET; COHORT ANALYSIS; COST OF ILLNESS; ECONOMICS; HOSPITAL; MALE; MEXICO; NICARAGUA; PANAMA; PUERTO RICO; THAILAND;

ADULT; BUDGETS; COHORT STUDIES; COST OF ILLNESS; DENGUE; HEALTH POLICY; HOSPITALS; HUMANS; INCIDENCE; MALE; MEXICO; NICARAGUA; PANAMA; PROSPECTIVE STUDIES; PUERTO RICO; QUALITY-ADJUSTED LIFE YEARS; THAILAND;

EID: 84928809326     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003547     Document Type: Article

References (116)

1. Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, et al. (2012) Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis 6: e1760. doi: 10.1371/journal.pntd.0001760 22880140
2. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, et al. (2013) The global distribution and burden of dengue. Nature 496: 504–507. doi: 10.1038/nature12060 23563266
3. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, et al. (2010) Dengue: a continuing global threat. Nat Rev Microbiol 8: S7–S16. doi: 10.1038/nrmicro2460 21079655
4. Simmons CP, Farrar JJ, Nguyen VVC, Wills B, (2012) Current concepts: dengue. N Engl J Med 366: 1423–1432. doi: 10.1056/NEJMra1110265 22494122
5. Gómez-Dantés H, Farfán-Ale JA, Sarti E, (2014) Epidemiological trends of dengue disease in Mexico (2000–2011): A systematic literature search and analysis. PLoS Negl Trop Dis 8: e3158. doi: 10.1371/journal.pntd.0003158 25375162
6. Cuddehe M, (2009) Mexico fights rise in dengue fever. Lancet 374: 602–602. 19708101
7. Diaz FJ, Black WC, Farfan-Ale JA, Lorono-Pino MA, Olson KE, et al. (2006) Dengue virus circulation and evolution in Mexico: A phylogenetic perspective. Arch Med Res 37: 760–773. 16824937
8. Secretaría de Salud México, 2012. Perfil epidemiológico del dengue en México. Available at: http://www.epidemiologia.salud.gob.mx/doctos/infoepid/publicaciones/2012/Monografia_Dengue_2012.pdf. Accessed 23 October, 2013.
9. Hernández-Ávila JE, Rodríguez M-H, Santos-Luna R, Sánchez-Castañeda V, Román-Pérez S, et al. (2013) Nation-wide, web-based, geographic information system for the integrated surveillance and control of dengue fever in Mexico. PLoS One 8: e70231. doi: 10.1371/journal.pone.0070231 23936394
10. Ramírez-Zepeda MG, Velasco-Mondragón HE, Ramos C, Peñuelas JE, Maradiaga-Ceceña MA, et al. (2009) Caracterización clínica y epidemiológica de los casos de dengue: experiencia del Hospital General de Culiacán, Sinaloa, México. Rev Panam Salud Publica 25: 16–23. 19341519
11. Navarrete-Espinosa J, Gomez-Dantes H, Celis-Quintal JG, Vazquez-Martinez JL, (2005) Clinical profile of dengue hemorrhagic fever cases in Mexico. Salud Publica Mex 47: 193–200. 16104461
12. Torresi J, Tapia-Conyer R, Margolis H, (2013) Preparing for dengue vaccine introduction: Recommendations from the 1st dengue v2V international meeting. PLoS Negl Trop Dis 7: e2261. doi: 10.1371/journal.pntd.0002261 24086776
13. Chan M, Kazatchkine M, Lob-Levyt J, Obaid T, Schweizer J, et al. (2010) Meeting the demand for results and accountability: A call for action on health data from eight global health agencies. PLoS Med 7: e1000223. doi: 10.1371/journal.pmed.1000223 20126260
14. Conteh L, Engels T, Molyneux DH, (2010) Neglected Tropical Diseases 4 Socioeconomic aspects of neglected tropical diseases. Lancet 375: 239–247. doi: 10.1016/S0140-6736(09)61422-7 20109925
15. Kallenberg J, Nguyen A, 2013. Vaccine investment strategy. Report to the GAVI Alliance board. Available at: http://www.gavialliance.org/about/strategy/vaccine-investment-strategy/. Accessed 20 November, 2013.
16. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, et al. (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2197–2223. doi: 10.1016/S0140-6736(12)61689-4 23245608
17. Hotez PJ, Alvarado M, Basáñez M-G, Bolliger I, Bourne R, et al. (2014) The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Negl Trop Dis 8: e2865. doi: 10.1371/journal.pntd.0002865 25058013
18. Armien B, Arredondo J, Carabali M, Carrasquilla G, Castro R, et al., 2012. Costing dengue cases and outbreaks: A guide to current practices and procedures. Available at: http://www.denguevaccines.org/sites/default/files/IVAC-DConstenla-Costing-Dengue-Cases-And-Outbreaks-Guide-To-Current-Practices_0.pdf. Accessed 15 September, 2013.
19. Shepard DS, Undurraga EA, Betancourt-Cravioto M, Guzmán MG, Halstead SB, et al. (2014) Approaches to refining estimates of global burden and economics of dengue. PLoS Negl Trop Dis 8: e3306. doi: 10.1371/journal.pntd.0003306 25412506
20. Secretaría de Salud México, 2007. Manual para la vigilancia, diagnóstico, prevención y control del dengue. Available at: http://www.pediatria.gob.mx/sgc/manussa_den.pdf. Accessed 23 October, 2013.
21. Secretaría de Salud México, 2008. Lineamientos para la vigilancia epidemiológica de fiebre por dengue y fiebre hemorrágica por dengue. Available at: http://visita.jalisco.gob.mx/wps/wcm/connect/bacff4804f18ffeda7e2b7de436ef780/Lineamientos+dengue.pdf?MOD=AJPERES Accessed 25 October, 2013.
22. Gubler DJ, (2002) How effectively is epidemiological surveillance used for dengue programme planning and epidemic response? Dengue Bull 26: 96–106.
23. Beatty ME, Stone A, Fitzsimons DW, Hanna JN, Lam SK, et al. (2010) Best practices in dengue surveillance: A report from the Asia-Pacific and Americas Dengue Prevention Boards. PLoS Negl Trop Dis 4: e890. doi: 10.1371/journal.pntd.0000890 21103381
24. Vong S, Goyet S, Ly S, Ngan C, Huy R, et al. (2012) Under-recognition and reporting of dengue in Cambodia: a capture-recapture analysis of the National Dengue Surveillance System. Epidemiol Infect 140: 491–499. doi: 10.1017/S0950268811001191 21733251
25. Standish K, Kuan G, Aviles W, Balmaseda A, Harris E, (2010) High dengue case capture rate in four years of a cohort study in Nicaragua compared to national surveillance data. PLoS Negl Trop Dis 4: e633. doi: 10.1371/journal.pntd.0000633 20300515
26. Wichmann O, Yoon IK, Vong S, Limkittikul K, Gibbons RV, et al. (2011) Dengue in Thailand and Cambodia: An assessment of the degree of underrecognized disease burden based on reported cases. PLoS Negl Trop Dis 5: e996. doi: 10.1371/journal.pntd.0000996 21468308
27. Gómez-Dantés H, Willoquet JR, (2009) Dengue in the Americas: challenges for prevention and control. Cad Saude Publica 25: S19–S31. 19287863
28. Duarte HHP, Franca EB, (2006) Data quality of dengue epidemiological surveillance in Belo Horizonte, Southeastern Brazil. Rev Saude Publica 40: 134–142. 16410994
29. Guzman MG, Jaenisch T, Gaczkowski R, Vo TTH, Sekaran SD, et al. (2010) Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis. PLoS Negl Trop Dis 4: e811. doi: 10.1371/journal.pntd.0000811 20824173
30. Racloz V, Ramsey R, Tong SL, Hu WB, (2012) Surveillance of dengue fever virus: A review of epidemiological models and early warning systems. PLoS Negl Trop Dis 6: e1648. doi: 10.1371/journal.pntd.0001648 22629476
31. Badurdeen S, Valladares DB, Farrar J, Gozzer E, Kroeger A, et al. (2013) Sharing experiences: towards an evidence based model of dengue surveillance and outbreak response in Latin America and Asia. BMC Public Health 13.
32. Ooi EE, Gubler D, Nam V (2007) Dengue research needs related to surveillance and emergency response. Report to the Scientific Working Group Meeting on Dengue, Geneva, 1–5 October, 2006. Geneva: World Health Organization WHO. 124–133 p.
33. Berntsen CF, Syverud KH, (2009) The dengue prevention, surveillance and control programme in the state of Morelos, Mexico. Oslo, Norway: University of Oslo. 65 p.
34. Undurraga EA, Halasa YA, Shepard DS, (2013) Use of expansion factors to estimate the burden of dengue in Southeast Asia: A systematic analysis. PLoS Negl Trop Dis 7: e2056. doi: 10.1371/journal.pntd.0002056 23437407
35. TDR/WHO, 2009. Dengue: Guidelines for diagnosis, treatment, prevention and control. New edition. Available at: http://whqlibdoc.who.int/publications/2009/9789241547871_eng.pdf. Accessed January 13, 2012.
36. Secretaría de Salud México, 2014. Semana epidemiológica. Available at: http://www.epidemiologia.salud.gob.mx/dgae/panodengue/intd_dengue.html. Accessed December 15, 2014.
37. McGraw EA, O’Neill SL, (2013) Beyond insecticides: New thinking on an ancient problem. Nat Rev Microbiol 11: 181–193. doi: 10.1038/nrmicro2968 23411863
38. Wise de Valdez MR, Nimmo D, Betz J, Gong H-F, James AA, et al. (2011) Genetic elimination of dengue vector mosquitoes. Proc Natl Acad Sci 108: 4772–4775. doi: 10.1073/pnas.1019295108 21383140
39. Capeding MR, Tran NH, Hadinegoro SRS, Ismail HIHJM, Chotpitayasunondh T, et al. (2014) Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet Online July 11.
40. Hoffmann AA, Montgomery BL, Popovici J, Iturbe-Ormaetxe I, Johnson PH, et al. (2011) Successful establishment of Wolbachia in Aedes populations to suppress dengue transmission. Nature 476: 454–457. doi: 10.1038/nature10356 21866160
41. Gubler DJ, (2011) Prevention and control of Aedes aegypti-borne diseases: lesson learned from past successes and failures. Asia Pac J Mol Biol Biotechnol 19: 111–114.
42. Tapia-Conyer R, Mendez-Galvan J, Burciaga-Zuniga P, (2012) Community participation in the prevention and control of dengue: the patio limpio strategy in Mexico. Paediatr Int Child Health 32 Suppl 1: 10–13. doi: 10.1179/2046904712Z.00000000047 22668443
43. Secretaría de Salud México, 2008. Programa de acción específico de dengue 2007–2012. Available at: http://www.spps.gob.mx/images/stories/SPPS/Docs/proy_prog/11._pcd.pdf. Accessed 4 November, 2013.
44. Shepard DS, Coudeville L, Halasa YA, Zambrano B, Dayan GH, (2011) Economic impact of dengue illness in the Americas. Am J Trop Med Hyg 84: 200–207. doi: 10.4269/ajtmh.2011.10-0503 21292885
45. Armien B, Suaya JA, Quiroz E, Sah BK, Bayard V, et al. (2008) Clinical characteristics and national economic cost of the 2005 dengue epidemic in Panama. Am J Trop Med Hyg 79: 364–371. 18784227
46. Suaya JA, Shepard DS, Siqueira JB, Martelli CT, Lum LCS, et al. (2009) Cost of dengue cases in eight countries in the Americas and Asia: A prospective study. Am J Trop Med Hyg 80: 846–855. 19407136
47. Halasa YA, Shepard DS, Zeng W, (2012) Economic cost of dengue in Puerto Rico. Am J Trop Med Hyg 86: 745–752. doi: 10.4269/ajtmh.2012.11-0784 22556069
48. Valdes L, Mizhrahi J, Guzman M, (2002) Economic impact of dengue 2 epidemic in Santiago de Cuba, 1997]. Rev Cubana Med Trop 54: 220. 15846947
49. Wettstein ZS, Fleming M, Chang AY, Copenhaver DJ, Wateska AR, et al. (2012) Total economic cost and burden of dengue in Nicaragua: 1996–2010. Am J Trop Med Hyg 87: 616–622. doi: 10.4269/ajtmh.2012.12-0146 22890033
50. Tarragona S, Monteverde M, Marchioni S, Caporale J, Pereiro AC, et al. (2012) Dengue in Argentina: An economic analysis of the impact of the 2009 epidemic. Salud Colect 8: 151–162. doi: 10.1590/S1851-82652012000200004 23995543
51. Anez G, Balza R, Valero N, Larreal Y, (2006) Economic impact of dengue and dengue hemorrhagic fever in the State of Zulia, Venezuela, 1997–2003. Rev Panam Salud Publica 19: 314–320. 16805973
52. Meltzer MI, Rigau-Perez JG, Clark GG, Reiter P, Gubler DJ, (1998) Using disability-adjusted life years to assess the economic impact of dengue in Puerto Rico: 1984–1994. Am J Trop Med Hyg 59: 265–271. 9715944
53. Betancourt-Cravioto M, Kuri-Morales P, González-Roldán JF, Tapia-Conyer R, the Mexican Dengue Expert G (2014) Introducing a dengue vaccine to Mexico: Development of a system for evidence-based public policy recommendations. PLoS Negl Trop Dis 8: e3009. doi: 10.1371/journal.pntd.0003009 25077478
54. Kongsin S, Jiamton S, Suaya J, Vasanawathana S, Sirisuvan P, et al. (2010) Cost of dengue in Thailand. Dengue Bull 34: 77–88.
55. World Health Organization, 2008. The global burden of disease: 2004 update. Available at: http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf. Accessed January, 2012.
56. Murray CJL, (1994) Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ 72: 429–445. 8062401
57. Shepard DS, Undurraga EA, Halasa YA, (2013) Economic and disease burden of dengue in Southeast Asia. PLoS Negl Trop Dis 7: e2055. doi: 10.1371/journal.pntd.0002055 23437406
58. World Bank, 2013. World development indicators. Available at: http://data.worldbank.org/indicator/. Accessed 20 October, 2013.
59. Shepard DS, Halasa YA, Undurraga EA, Gubler DJ, Ooi Ee, Vasudevan SG, Farrar J, (2014) Economic and disease burden of dengue. In: Dengue and Dengue Hemorrhagic Fever. 2nd ed. Wallingford, UK: CAB International. pp. 50–77. doi: 10.1016/j.ijid.2014.04.014 25108077
60. Martínez-Vega RA, Galeana-Hernández M, Amaya-Larios IY, Danis-Lozano R, Velasco-Hernández J, et al. (2012) Peridomestic infection as a determinant of dengue transmission in two endemic localities of Mexico. 61st Annual Meeting of the American Society of Tropical Medicine and Hygiene. Atlanta, GA.
61. Martínez-Vega RA, Danis-Lozano R, Velasco-Hernández J, Díaz-Quijano FA, González-Fernández M, et al. (2012) A prospective cohort study to evaluate peridomestic infection as a determinant of dengue transmission: Protocol. BMC Public Health 12: 262. doi: 10.1186/1471-2458-12-262 22471857
62. Noecker CA, Amaya-Larios IY, Galeana-Hernandez M, Ramos-Castaneda J, Martinez-Vega RA, (2014) Contrasting associations of polymorphisms in FcgammaRIIa and DC-SIGN with the clinical presentation of dengue infection in a Mexican population. Acta Trop 138c: 15–22.
63. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, et al. (1997) Dengue in the early febrile phase: Viremia and antibody responses. J Infect Dis 176: 322–330. 9237696
64. Groen J, Koraka P, Velzing J, Copra C, Osterhaus A, (2000) Evaluation of six immunoassays for detection of dengue virus-specific immunoglobulin M and G antibodies. Clin Diagn Lab Immunol 7: 867–871. 11063489
65. Lozano R, Soliz P, Gakidou E, Abbott-Klafter J, Feehan DM, et al. (2006) Benchmarking of performance of Mexican states with effective coverage. Lancet 368: 1729–1741. 17098091
66. Secretaría de Salud México, 2013. Sistema Nacional de Información en Salud. Available at: http://www.sinais.salud.gob.mx. Accessed 1 November, 2012.
67. World Health Organization, 2011. Choosing interventions that are cost effective (WHO—CHOICE). Available at: http://www.who.int/choice/en/. Accessed January 4, 2011.
68. Secretaría de Desarrollo Social (1999) Sistema Normativo de Equipamiento Urbano. Tomo II: Salud y Asistencia Social. Mexico DF: Dirección General de Infraestructura y Equipamiento.
69. Carabin H, Gyorkos TW, Soto JC, Joseph L, Payment P, et al. (1999) Effectiveness of a training program in reducing infections in toddlers attending day care centers. Epidemiology 10: 219–227. 10230828
70. Dávila E, Guijarro M, 2000. Evolución y reforma del sistema de salud en México. Available at: http://www.cepal.org/es/publicaciones/evolucion-y-reforma-del-sistema-de-salud-en-mexico. Accessed 91.
71. World Health Organization, 2008. WHO guide for standardization of economic evaluations of immunization programmes. Available at: www.who.int/vaccines-documents/. Accessed November 2, 2011.
72. Centro Nacional de Evaluación para la Educación Superior, 2009. Cifras e indicadores del sistema educativo nacional 2007–2008. Available at: http://archivos.ceneval.edu.mx/archivos_portal/862/CIFRAS_INDICADORES_SEN2007-2008.pdf Accessed 20 September, 2013.
73. Instituto Nacional de Estadística y Geografía, 2013. Anuario estadístico de los Estados Unidos Mexicanos 2012. Available at: http://www3.inegi.org.mx/sistemas/productos/default.aspx?c=265&s=inegi&upc=702825054021&pf=Prod&ef=&f=2&cl=0&tg=8&pg=0. Accessed Jan 16, 2014.
74. Secretaría de Educación Pública México, 2009. Organización del trabajo en las escuelas de tiempo completo. Available at: http://basica.sep.gob.mx/tiempocompleto/pdf/Estrategias_final_baja.pdf. Accessed 15 September, 2012.
75. World Health Organization, 2009. Life tables for WHO member states for year 2009. Available at: http://www.who.int/healthinfo/statistics/mortality_life_tables/en/. Accessed September 22, 2011.
76. Mavalankar D, Puwar TI, Murtola TM, Vasan S, Field RW, et al. (2009) Quantifying the impact of chikungunya and dengue on tourism revenues. IIMA Working Paper No2009–02–03. Ahmedabad, India: Indian Institute of Management.
77. Wilder-Smith A, Schwartz E, (2005) Current concepts: Dengue in travelers. N Engl J Med 353: 924–932. 16135837
78. Barnighausen T, Bloom DE, Cafiero ET, O’Brien J, (2013) Valuing the broader benefits of dengue vaccination, with a preliminary application to Brazil. Seminars in Immunology 25: 104–113. doi: 10.1016/j.smim.2013.04.010 23886895
79. de Moura Costal GA, (2004) O impacto econômico do dengue no turismo. Revista Turismo em Análise 15: 13–21.
80. Tan PC, Soe MZ, Si Lay K, Wang SM, Sekaran SD, et al. (2012) Dengue infection and miscarriage: A prospective case control study. PLoS Negl Trop Dis 6: e1637. doi: 10.1371/journal.pntd.0001637 22590658
81. Davis JS, Bourke P, (2004) Rhabdomyolysis associated with dengue virus infection. Clin Infect Dis 38: e109. 15156504
82. Dinh TT, Le TTT, Tran TH, Nguyen TH, Nguyen NV, et al. (2010) Liver involvement associated with dengue infection in adults in Vietnam. Am J Trop Med Hyg 83: 774–780. doi: 10.4269/ajtmh.2010.10-0090 20889864
83. Larik A, Chiong Y, Lee LC, Ng YS (2012) Longitudinally extensive transverse myelitis associated with dengue fever. BMJ Case Reports 2012.
84. Laoprasopwattana K, Pruekprasert P, Dissaneewate P, Geater A, Vachvanichsanong P, (2010) Outcome of dengue hemorrhagic fever-caused acute kidney injury in Thai children. J Pediatr 157: 303–309. doi: 10.1016/j.jpeds.2010.02.008 20362302
85. Solomon T, Dung NM, Vaughn DW, Kneen R, Thao LTT, et al. (2000) Neurological manifestations of dengue infection. Lancet 355: 1053–1059. 10744091
86. Banker RD, Datar SM, Kekre S, (1988) Relevent costs, congestion, and stochasticity in production environments. Journal of Accounting & Economics 10: 171–197.
87. Cuong HQ, (2013) Spatiotemporal dynamics of dengue epidemics, Southern Vietnam. Emerg Infect Dis 19: 945–953. doi: 10.3201/eid1906.121323 23735713
88. Cummings DAT, Irizarry RA, Huang NE, Endy TP, Nisalak A, et al. (2004) Travelling waves in the occurrence of dengue haemorrhagic fever in Thailand. Nature 427: 344–347. 14737166
89. Liebman KA, Stoddard ST, Morrison AC, Rocha C, Minnick S, et al. (2012) Spatial dimensions of dengue virus transmission across interepidemic and epidemic periods in Iquitos, Peru (1999–2003). PLoS Negl Trop Dis 6: e1472. doi: 10.1371/journal.pntd.0001472 22363822
90. Mammen MP, Pimgate C, Koenraadt CJM, Rothman AL, Aldstadt J, et al. (2008) Spatial and temporal clustering of dengue virus transmission in Thai villages. PLoS Med 5: 1605–1616.
91. Luz PM, Grinsztejn B, Galvani AP, (2009) Disability adjusted life years lost to dengue in Brazil. Trop Med Int Health 14: 237–246. doi: 10.1111/j.1365-3156.2008.02203.x 19171013
92. Structured Data LLC, 2007. RiskAMP user guide. Available at: www.riskamp.com. Accessed June, 2012.
93. Endy TP, Chunsuttiwat S, Nisalak A, Libraty DH, Green S, et al. (2002) Epidemiology of inapparent and symptomatic acute dengue virus infection: A prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol 156: 40–51. 12076887
94. Gordon A, Kuan G, Mercado JC, Gresh L, Avilés W, et al. (2013) The nicaraguan pediatric dengue cohort study: Incidence of inapparent and symptomatic dengue virus infections, 2004–2010. PLoS Negl Trop Dis 7: e2462. doi: 10.1371/journal.pntd.0002462 24086788
95. Porter KR, Beckett CG, Kosasih H, Tan RI, Alisjahbana B, et al. (2005) Epidemiology of dengue and dengue hemorrhagic fever in a cohort of adults living in Bandung, west Java, Indonesia. Am J Trop Med Hyg 72: 60–66. 15728868
96. Tien NTK, Luxemburger C, Toan NT, Pollissard-Gadroy L, Houng VTQ, et al. (2010) A prospective cohort study of dengue infection in schoolchildren in Long Xuyen, Viet Nam. Trans Roy Soc Trop Med Hyg 104: 592–600. doi: 10.1016/j.trstmh.2010.06.003 20630553
97. Shepard DS, Undurraga EA, Lees RS, Halasa YA, Lum L, et al. (2012) Use of multiple data sources to estimate the economic cost of dengue illness in Malaysia. Am J Trop Med Hyg 87: 796–805. doi: 10.4269/ajtmh.2012.12-0019 23033404
98. Shepard DS, Hodgkin D, Anthony YE (2000) Analysis of Hospital Costs: a Manual for Managers. Geneva, Switzerland: World Health Organization.
99. Serdan-Rosales A, 2011. Panorama del gasto educativo en México 2012. Available at: http://www.porlaeducacion.com/archivos/Panorama%20del%20gasto%20educativo%202012.pdf. Accessed 15 September, 2012.
100. Granados-García V, Velázquez FR, Salmerón J, Homedes N, Salinas-Escudero G, et al. (2011) Burden of disease and costs of treating rotavirus diarrhea in Mexican children for the period 2001–2006. Vaccine 29: 6712–6719. doi: 10.1016/j.vaccine.2011.03.020 21439316
101. Tapia-Conyer R, Mendez-Galvan JF, Gallardo-Rincon H, (2009) The growing burden of dengue in Latin America. J Clin Virol 46: S3–S6. doi: 10.1016/S1386-6532(09)70286-0 19800563
102. Secretaría de Salud México, 2012. Encuesta Nacional de Salud y Nutrición 2012. Available at: http://ensanut.insp.mx/. Accessed January 23, 2014.
103. Baly A, Toledo ME, Rodriguez K, Benitez JR, Rodriguez M, et al. (2012) Costs of dengue prevention and incremental cost of dengue outbreak control in Guantanamo, Cuba. Trop Med Int Health 17: 123–132. doi: 10.1111/j.1365-3156.2011.02881.x 21906216
104. Garcia G, Gonzalez N, Perez AB, Sierra B, Aguirre E, et al. (2011) Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disorders. Int J Infect Dis 15: E38–E43. doi: 10.1016/j.ijid.2010.09.008 21112804
105. Gonzalez D, Martinez R, Castro O, Serrano T, Portela D, et al. (2005) Evaluation of some clinical, humoral, and imagenological parameters in patients of dengue haemorrhagic fever six months after acute illness. Dengue Bull 29: 79–84.
106. Seet RCS, Quek AML, Lim ECH, (2007) Post-infectious fatigue syndrome in dengue infection. J Clin Virol 38: 1–6. 17137834
107. Teixeira LDS, Lopes JSM, Martins AGD, Campos FAB, Miranzi SDC, et al. (2010) Persistence of dengue symptoms in patients in Uberaba, Minas Gerais State, Brazil. Cad Saude Publica 26: 625–630.
108. Tristao-Sa R, Kubelka CF, Zandonade E, Zagne SMO, Rocha NDM, et al. (2012) Clinical and hepatic evaluation in adult dengue patients: a prospective two-month cohort study. Revista Da Sociedade Brasileira De Medicina Tropical 45: 675–681. 23295867
109. Halsey ES, Williams M, Laguna-Torres VA, Vilcarromero S, Ocaña V, et al. (2014) Occurrence and correlates of symptom persistence following acute dengue fever in Peru. Am J Trop Med Hyg Published online Jan 27 2014.
110. World Health Organization, 1997. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. Available at: http://www.who.int/csr/resources/publications/dengue/Denguepublication/en/. Accessed October, 2012.
111. Gubler DJ, (2012) The economic burden of dengue. Am J Trop Med Hyg 86: 743. doi: 10.4269/ajtmh.2012.12-0157 22556068
112. Webster DP, Farrar J, Rowland-Jones S, (2009) Progress towards a dengue vaccine. Lancet Infect Dis 9: 678–687. doi: 10.1016/S1473-3099(09)70254-3 19850226
113. Wilder-Smith A, Byass P, Olanratmanee P, Maskhao P, Sringernyuang L, et al. (2012) The impact of insecticide-treated school uniforms on dengue infections in school-aged children: study protocol for a randomised controlled trial in Thailand. Trials 13.
114. Douglas DL, DeRoeck DA, Mahoney RT, Wichmann O, (2013) Will dengue vaccines be used in the public sector and if so, how? Findings from an 8-country survey of policymakers and opinion leaders. PLoS Negl Trop Dis 7: e2127. doi: 10.1371/journal.pntd.0002127 23516658
115. Villar L, Dayan GH, Arredondo-García JL, Rivera DM, Cunha R, et al. (2014) Efficacy of a tetravalent dengue vaccine in children in Latin America. N Engl J Med 0: Available online November 3.
116. San Martín JL, Brathwaite-Dick O, (2007) La estrategia de gestión integrada para la prevención y el control del dengue en la región de las Américas. Rev Panam Salud Publica 21: 55–63. 17439693